57236-72-3 Usage
Molecular structure
1-O-Acetyl-2-deoxy-3,5-di-O-(4-methylbenzoyl)-beta-D-erythropentofuranose consists of a beta-D-erythropentofuranose sugar molecule with an acetyl group (CH3CO-), a deoxy group (H), and two 4-methylbenzoyl groups (C8H7O2-) attached to it.
Derivative of erythropentofuranose
It is a derivative of erythropentofuranose, which is a type of sugar.
Complex chemical compound
The compound is a complex chemical compound due to its multiple functional groups and the arrangement of atoms in its structure.
Usage in chemical synthesis
It is often used in the chemical synthesis of other compounds, making it a valuable reagent in organic chemistry.
Application in research and pharmaceutical synthesis
The compound is commonly used in research and pharmaceutical synthesis due to its unique properties and complex structure.
Functional groups
The compound contains an acetyl group, a deoxy group, and a benzoyl group, which contribute to its reactivity and versatility in chemical reactions.
Stereochemistry
The compound has a beta (β) configuration, which refers to the arrangement of atoms in three-dimensional space, affecting its properties and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 57236-72-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,2,3 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 57236-72:
(7*5)+(6*7)+(5*2)+(4*3)+(3*6)+(2*7)+(1*2)=133
133 % 10 = 3
So 57236-72-3 is a valid CAS Registry Number.
57236-72-3Relevant academic research and scientific papers
ACADESINE DERIVATIVES, PRODUCTS AND COMPOSITIONS INCLUDING SAME, THERAPUETIC USES THEREOF, AND METHODS FOR SYNTHESIZING SAME
-
Paragraph 0328, (2014/07/08)
Acadesine derivatives as a drug, as well as the derivatives for the treatment of cancer and in particular for the treatment of chronic myeloid leukemia are described. Also, product containing the derivatives and at least one second active ingredient as a
